Product Information
POTASSIUM CHLORIDE 10% (20 MEQ/15 ML) ORAL LIQUID is a generic product labeled by Endo USA Inc., priced at $0.0408 per ML under NDC 00603154258. Its NADAC has been published 586 times since Jul 15, 2015.
FDA first approved this application on Dec 22, 2014. Its Orange Book therapeutic-equivalence code is AA.
Strength
20 meq/15mL
Manufacturer
Endo USA Inc.NDC
00603154258
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
POTASSIUM CHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA206814FDA Approved
12/22/2014
TE Code
AA
On Market Since
5/4/2015
Pharmacological Classes
Price Statistics
The NADAC for POTASSIUM CHLORIDE 10% (20 MEQ/15 ML) ORAL LIQUID has been published 586 times since Jul 15, 2015, and over the history we have for it it has declined 24.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0408 per ML |
|---|---|
| All-time high | $0.4717 (Dec 14, 2016) |
| All-time low | $0.0279 (Nov 20, 2024) |
| 52-week high | $0.0414 |
| 52-week low | $0.0372 |
| Median price | $0.2042 |
| Average price | $0.2095 |
| Largest weekly change | +346.0% (Oct 21, 2015) |
| Weeks tracked | 586 |
| Tracking since | Jul 15, 2015 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 3% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Endo USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Potassium Chloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Osmotic Laxative class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of POTASSIUM CHLORIDE 10% (20 MEQ/15 ML) ORAL LIQUID?
The current National Average Drug Acquisition Cost (NADAC) for POTASSIUM CHLORIDE 10% (20 MEQ/15 ML) ORAL LIQUID, manufactured by Endo USA Inc., is $0.0408 per ML (NDC 00603154258), effective Sep 30, 2026.
How has the price of POTASSIUM CHLORIDE 10% (20 MEQ/15 ML) ORAL LIQUID changed over time?
Over the history we have for it, the NADAC for POTASSIUM CHLORIDE 10% (20 MEQ/15 ML) ORAL LIQUID has declined 24.5%. It has been tracked across 586 weekly CMS publications since Jul 15, 2015.
What are the highest and lowest recorded NADAC prices for POTASSIUM CHLORIDE 10% (20 MEQ/15 ML) ORAL LIQUID?
Since Jul 15, 2015, the NADAC for POTASSIUM CHLORIDE 10% (20 MEQ/15 ML) ORAL LIQUID has ranged from a low of $0.0279 (Nov 20, 2024) to a high of $0.4717 (Dec 14, 2016), with a median of $0.2042 per ML.
Are there cheaper alternatives to POTASSIUM CHLORIDE 10% (20 MEQ/15 ML) ORAL LIQUID?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, POTASSIUM CHLORIDE 10% (20 MEQ/15 ML) ORAL LIQUID, is $0.0395 per ML — about 3% below POTASSIUM CHLORIDE 10% (20 MEQ/15 ML) ORAL LIQUID.
Who manufactures POTASSIUM CHLORIDE 10% (20 MEQ/15 ML) ORAL LIQUID?
POTASSIUM CHLORIDE 10% (20 MEQ/15 ML) ORAL LIQUID (NDC 00603154258) is labeled by Endo USA Inc., and CMS classifies it as a generic product.